According to these studies, abolishing autophagy initiation by inhibiting the activation of Erk1/2, p38, and NF-κB signals in tumor-derived neutrophils could rapidly restore the spontaneous apoptosis of cells, which provides a novel strategy for anti-tumor therapy [110]. This evidence concerns the gene MAPK3 and neoplasm.